<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Hip Knee Book &#187; Cancer</title>
	<atom:link href="http://www.hipkneebook.com/tag/cancer/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.hipkneebook.com</link>
	<description>Treating Arthritis of the Hip and Knee</description>
	<lastBuildDate>Thu, 29 Jul 2010 22:55:23 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.9.2</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Biologics-Naive Juvenile Idiopathic Arthritis Patients Have Elevated Risk Of Cancer</title>
		<link>http://www.hipkneebook.com/main-content/biologics-naive-juvenile-idiopathic-arthritis-patients-have-elevated-risk-of-cancer-2/</link>
		<comments>http://www.hipkneebook.com/main-content/biologics-naive-juvenile-idiopathic-arthritis-patients-have-elevated-risk-of-cancer-2/#comments</comments>
		<pubDate>Thu, 17 Jun 2010 23:17:42 +0000</pubDate>
		<dc:creator>Content Keyword RSS</dc:creator>
				<category><![CDATA[Main Content]]></category>
		<category><![CDATA[Arthritis]]></category>
		<category><![CDATA[Arthritis Patients]]></category>
		<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Congress]]></category>
		<category><![CDATA[Eular]]></category>
		<category><![CDATA[Juvenile Arthritis]]></category>
		<category><![CDATA[Juvenile Idiopathic Arthritis]]></category>
		<category><![CDATA[Rheumatism]]></category>
		<category><![CDATA[Risk]]></category>
		<category><![CDATA[Rome Italy]]></category>
		<category><![CDATA[Swedish Population]]></category>

		<guid isPermaLink="false">http://www.redorbit.com/news/health/1881231/biologicsnaive_juvenile_idiopathic_arthritis_patients_have_elevated_risk_of_cancer/index.html?source=r_health</guid>
		<description><![CDATA[Biologics-na�ve Juvenile Idiopathic Arthritis (JIA) patients may have an increased risk of cancer compared with the general Swedish population, according to research presented today at EULAR 2010, the Annual Congress of the European League Against Rheumatism in Rome, Italy.]]></description>
			<content:encoded><![CDATA[Biologics-na�ve Juvenile Idiopathic Arthritis (JIA) patients may have an increased risk of cancer compared with the general Swedish population, according to research presented today at EULAR 2010, the Annual Congress of the European League Against Rheumatism in Rome, Italy.]]></content:encoded>
			<wfw:commentRss>http://www.hipkneebook.com/main-content/biologics-naive-juvenile-idiopathic-arthritis-patients-have-elevated-risk-of-cancer-2/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Biologics-naive juvenile idiopathic arthritis patients have elevated risk of cancer</title>
		<link>http://www.hipkneebook.com/main-content/biologics-naive-juvenile-idiopathic-arthritis-patients-have-elevated-risk-of-cancer/</link>
		<comments>http://www.hipkneebook.com/main-content/biologics-naive-juvenile-idiopathic-arthritis-patients-have-elevated-risk-of-cancer/#comments</comments>
		<pubDate>Thu, 17 Jun 2010 13:32:39 +0000</pubDate>
		<dc:creator>Content Keyword RSS</dc:creator>
				<category><![CDATA[Main Content]]></category>
		<category><![CDATA[Arthritis]]></category>
		<category><![CDATA[Arthritis Patients]]></category>
		<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Cohort]]></category>
		<category><![CDATA[Congress]]></category>
		<category><![CDATA[Eular]]></category>
		<category><![CDATA[Juvenile Arthritis]]></category>
		<category><![CDATA[Juvenile Idiopathic Arthritis]]></category>
		<category><![CDATA[Rheumatism]]></category>
		<category><![CDATA[Risk]]></category>
		<category><![CDATA[Rome Italy]]></category>
		<category><![CDATA[Swedish Population]]></category>

		<guid isPermaLink="false">http://www.eurekalert.org/pub_releases/2010-06/elar-bji061710.php</guid>
		<description><![CDATA[( European League Against Rheumatism ) Biologics-naive juvenile idiopathic arthritis patients may have an increased risk of cancer compared with the general Swedish population, according to research presented today at EULAR 2010, the Annual Congress of the European League Against Rheumatism in Rome, Italy. Results of an additional study, which researched a small cohort of patients showed an ...]]></description>
			<content:encoded><![CDATA[( European League Against Rheumatism ) Biologics-naive juvenile idiopathic arthritis patients may have an increased risk of cancer compared with the general Swedish population, according to research presented today at EULAR 2010, the Annual Congress of the European League Against Rheumatism in Rome, Italy. Results of an additional study, which researched a small cohort of patients showed an ...]]></content:encoded>
			<wfw:commentRss>http://www.hipkneebook.com/main-content/biologics-naive-juvenile-idiopathic-arthritis-patients-have-elevated-risk-of-cancer/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>VBL Therapeutics to Present Data on VB-201 for Rheumatoid Arthritis at EULAR Annual Meeting</title>
		<link>http://www.hipkneebook.com/main-content/vbl-therapeutics-to-present-data-on-vb-201-for-rheumatoid-arthritis-at-eular-annual-meeting/</link>
		<comments>http://www.hipkneebook.com/main-content/vbl-therapeutics-to-present-data-on-vb-201-for-rheumatoid-arthritis-at-eular-annual-meeting/#comments</comments>
		<pubDate>Thu, 10 Jun 2010 10:30:00 +0000</pubDate>
		<dc:creator>Content Keyword RSS</dc:creator>
				<category><![CDATA[Main Content]]></category>
		<category><![CDATA[Annual Meeting]]></category>
		<category><![CDATA[Arthritis]]></category>
		<category><![CDATA[Biotechnology Company]]></category>
		<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Clinical Stage]]></category>
		<category><![CDATA[European Congress]]></category>
		<category><![CDATA[Immune Diseases]]></category>
		<category><![CDATA[Inflammatory Diseases]]></category>
		<category><![CDATA[Israel]]></category>
		<category><![CDATA[Novel Treatments]]></category>
		<category><![CDATA[Preclinical Data]]></category>
		<category><![CDATA[Presentation]]></category>
		<category><![CDATA[Rheumatism]]></category>
		<category><![CDATA[Rheumatoid Arthritis]]></category>
		<category><![CDATA[Rheumatology]]></category>
		<category><![CDATA[Tel Aviv Israel]]></category>
		<category><![CDATA[Vb]]></category>
		<category><![CDATA[Vbl]]></category>

		<guid isPermaLink="false">http://biz.yahoo.com/bw/100610/20100610005151.html?.v=1</guid>
		<description><![CDATA[TEL AVIV, Israel----VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced the upcoming presentation of preclinical data from the companys lead program, VB-201, at the European League Against Rheumatism Annual European Congress of Rheumatology.]]></description>
			<content:encoded><![CDATA[TEL AVIV, Israel----VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced the upcoming presentation of preclinical data from the companys lead program, VB-201, at the European League Against Rheumatism Annual European Congress of Rheumatology.]]></content:encoded>
			<wfw:commentRss>http://www.hipkneebook.com/main-content/vbl-therapeutics-to-present-data-on-vb-201-for-rheumatoid-arthritis-at-eular-annual-meeting/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Teva Targets Roches Rituxan in Biosimilar Drug Trial (Update3)</title>
		<link>http://www.hipkneebook.com/main-content/teva-targets-roches-rituxan-in-biosimilar-drug-trial-update3/</link>
		<comments>http://www.hipkneebook.com/main-content/teva-targets-roches-rituxan-in-biosimilar-drug-trial-update3/#comments</comments>
		<pubDate>Tue, 25 May 2010 16:08:38 +0000</pubDate>
		<dc:creator>Content Keyword RSS</dc:creator>
				<category><![CDATA[Main Content]]></category>
		<category><![CDATA[Ags]]></category>
		<category><![CDATA[Arthritis]]></category>
		<category><![CDATA[Based Medicine]]></category>
		<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Diseases]]></category>
		<category><![CDATA[Generic Version]]></category>
		<category><![CDATA[Medicine]]></category>
		<category><![CDATA[Monoclonal Antibody]]></category>
		<category><![CDATA[Protein]]></category>
		<category><![CDATA[Rituxan]]></category>
		<category><![CDATA[Roche Holding]]></category>
		<category><![CDATA[Targets]]></category>
		<category><![CDATA[Teva Pharmaceutical Industries]]></category>
		<category><![CDATA[Teva Pharmaceutical Industries Ltd]]></category>

		<guid isPermaLink="false">http://www.businessweek.com/news/2010-05-25/teva-targets-roche-s-rituxan-in-biosimilar-drug-trial-update3-.html</guid>
		<description><![CDATA[Teva Pharmaceutical Industries Ltd. is testing a copy of Roche Holding AGs second-biggest-selling drug Rituxan in what may be the first U.S. generic version of a monoclonal antibody, a protein-based medicine used to treat diseases ranging from arthritis to cancer.]]></description>
			<content:encoded><![CDATA[Teva Pharmaceutical Industries Ltd. is testing a copy of Roche Holding AGs second-biggest-selling drug Rituxan in what may be the first U.S. generic version of a monoclonal antibody, a protein-based medicine used to treat diseases ranging from arthritis to cancer.]]></content:encoded>
			<wfw:commentRss>http://www.hipkneebook.com/main-content/teva-targets-roches-rituxan-in-biosimilar-drug-trial-update3/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Teva Targets Roches Rituxan in Biosimilar Drug Trial (Update1)</title>
		<link>http://www.hipkneebook.com/main-content/teva-targets-roches-rituxan-in-biosimilar-drug-trial-update1-2/</link>
		<comments>http://www.hipkneebook.com/main-content/teva-targets-roches-rituxan-in-biosimilar-drug-trial-update1-2/#comments</comments>
		<pubDate>Tue, 25 May 2010 10:47:45 +0000</pubDate>
		<dc:creator>Content Keyword RSS</dc:creator>
				<category><![CDATA[Main Content]]></category>
		<category><![CDATA[Arthritis]]></category>
		<category><![CDATA[Based Medicine]]></category>
		<category><![CDATA[Bloomberg]]></category>
		<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Diseases]]></category>
		<category><![CDATA[Generic Version]]></category>
		<category><![CDATA[Medicine]]></category>
		<category><![CDATA[Monoclonal Antibody]]></category>
		<category><![CDATA[Protein]]></category>
		<category><![CDATA[Rituxan]]></category>
		<category><![CDATA[Roche Holding Ag]]></category>
		<category><![CDATA[Targets]]></category>
		<category><![CDATA[Teva Pharmaceutical Industries]]></category>
		<category><![CDATA[Teva Pharmaceutical Industries Ltd]]></category>

		<guid isPermaLink="false">http://www.bloomberg.com/apps/news?sid=alLBLXdN2jFkpid=20601087</guid>
		<description><![CDATA[May 25 (Bloomberg) -- Teva Pharmaceutical Industries Ltd. is testing a copy of Roche Holding AG s second-biggest-selling drug Rituxan in what may be the first generic version of a monoclonal antibody, a protein-based medicine used to treat diseases ranging from arthritis to cancer.]]></description>
			<content:encoded><![CDATA[May 25 (Bloomberg) -- Teva Pharmaceutical Industries Ltd. is testing a copy of Roche Holding AG s second-biggest-selling drug Rituxan in what may be the first generic version of a monoclonal antibody, a protein-based medicine used to treat diseases ranging from arthritis to cancer.]]></content:encoded>
			<wfw:commentRss>http://www.hipkneebook.com/main-content/teva-targets-roches-rituxan-in-biosimilar-drug-trial-update1-2/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Teva Targets Roches Rituxan in Biosimilar Drug Trial (Update1)</title>
		<link>http://www.hipkneebook.com/main-content/teva-targets-roches-rituxan-in-biosimilar-drug-trial-update1/</link>
		<comments>http://www.hipkneebook.com/main-content/teva-targets-roches-rituxan-in-biosimilar-drug-trial-update1/#comments</comments>
		<pubDate>Tue, 25 May 2010 08:24:43 +0000</pubDate>
		<dc:creator>Content Keyword RSS</dc:creator>
				<category><![CDATA[Main Content]]></category>
		<category><![CDATA[Arthritis]]></category>
		<category><![CDATA[Based Medicine]]></category>
		<category><![CDATA[Bloomberg]]></category>
		<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Diseases]]></category>
		<category><![CDATA[Generic Version]]></category>
		<category><![CDATA[Medicine]]></category>
		<category><![CDATA[Monoclonal Antibody]]></category>
		<category><![CDATA[Protein]]></category>
		<category><![CDATA[Rituxan]]></category>
		<category><![CDATA[Roche Holding Ag]]></category>
		<category><![CDATA[Targets]]></category>
		<category><![CDATA[Teva Pharmaceutical Industries]]></category>
		<category><![CDATA[Teva Pharmaceutical Industries Ltd]]></category>

		<guid isPermaLink="false">http://www.bloomberg.com/apps/news?sid=a9CcBifXC9Fkpid=20601087</guid>
		<description><![CDATA[May 25 (Bloomberg) -- Teva Pharmaceutical Industries Ltd. is testing a copy of Roche Holding AG s second-biggest-selling drug Rituxan in what may be the first generic version of a monoclonal antibody, a protein-based medicine used to treat diseases ranging from arthritis to cancer.]]></description>
			<content:encoded><![CDATA[May 25 (Bloomberg) -- Teva Pharmaceutical Industries Ltd. is testing a copy of Roche Holding AG s second-biggest-selling drug Rituxan in what may be the first generic version of a monoclonal antibody, a protein-based medicine used to treat diseases ranging from arthritis to cancer.]]></content:encoded>
			<wfw:commentRss>http://www.hipkneebook.com/main-content/teva-targets-roches-rituxan-in-biosimilar-drug-trial-update1/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Latent Viruses Cause Cancer – Stop Latent Viruses with Gene-Eden, an Antiviral Supplement</title>
		<link>http://www.hipkneebook.com/main-content/latent-viruses-cause-cancer-%e2%80%93-stop-latent-viruses-with-gene-eden-an-antiviral-supplement-2/</link>
		<comments>http://www.hipkneebook.com/main-content/latent-viruses-cause-cancer-%e2%80%93-stop-latent-viruses-with-gene-eden-an-antiviral-supplement-2/#comments</comments>
		<pubDate>Fri, 16 Oct 2009 15:51:32 +0000</pubDate>
		<dc:creator>Content Keyword RSS</dc:creator>
				<category><![CDATA[Main Content]]></category>
		<category><![CDATA[Blood Pressures]]></category>
		<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Cell Phone Antenna]]></category>
		<category><![CDATA[Cholesterol]]></category>
		<category><![CDATA[Eden]]></category>
		<category><![CDATA[Immune System]]></category>
		<category><![CDATA[Radiation Uv]]></category>
		<category><![CDATA[Stress]]></category>
		<category><![CDATA[Viruses]]></category>
		<category><![CDATA[X Ray]]></category>

		<guid isPermaLink="false">http://www.tips-and-guides.com/2009/10/16/latent-viruses-cause-cancer-stop-latent-viruses-with-gene-eden-an-antiviral-supplement/</guid>
		<description><![CDATA[The immune system is powerful, yet delicate. Many events outside or inside our body can damage it. For instance, are you stressed? Are you taking medications to lower your cholesterol or blood pressures, or to control other long term conditions? Do you use your cell phone extensively? Do you live or work next to a cell phone antenna? Did you pass the age of 40? Stress, medications, radiation (UV, x-Ray, cell phone, etc), and aging damage your immune system. Why is and efficient immune system i]]></description>
			<content:encoded><![CDATA[The immune system is powerful, yet delicate. Many events outside or inside our body can damage it. For instance, are you stressed? Are you taking medications to lower your cholesterol or blood pressures, or to control other long term conditions? Do you use your cell phone extensively? Do you live or work next to a cell phone antenna? Did you pass the age of 40? Stress, medications, radiation (UV, x-Ray, cell phone, etc), and aging damage your immune system. Why is and efficient immune system i]]></content:encoded>
			<wfw:commentRss>http://www.hipkneebook.com/main-content/latent-viruses-cause-cancer-%e2%80%93-stop-latent-viruses-with-gene-eden-an-antiviral-supplement-2/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Nutrition And Supplements In Anti-Aging Medicine</title>
		<link>http://www.hipkneebook.com/main-content/nutrition-and-supplements-in-anti-aging-medicine/</link>
		<comments>http://www.hipkneebook.com/main-content/nutrition-and-supplements-in-anti-aging-medicine/#comments</comments>
		<pubDate>Thu, 15 Oct 2009 15:17:53 +0000</pubDate>
		<dc:creator>Content Keyword RSS</dc:creator>
				<category><![CDATA[Main Content]]></category>
		<category><![CDATA[Agricultural Methods]]></category>
		<category><![CDATA[Amino Acids]]></category>
		<category><![CDATA[Anti Aging Medicine]]></category>
		<category><![CDATA[Antioxidants]]></category>
		<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Diseases]]></category>
		<category><![CDATA[Essential Fatty Acids]]></category>
		<category><![CDATA[Food Chain]]></category>
		<category><![CDATA[Food Processing]]></category>
		<category><![CDATA[Heart Disease]]></category>
		<category><![CDATA[Medicine]]></category>
		<category><![CDATA[Nutrients]]></category>
		<category><![CDATA[Nutrition Supplements]]></category>
		<category><![CDATA[Supplementation]]></category>
		<category><![CDATA[Trace Minerals]]></category>
		<category><![CDATA[Vitamins Minerals]]></category>

		<guid isPermaLink="false">http://seasoningz.com/seasoningz-blog/nutrition-and-supplements-in-anti-aging-medicine/</guid>
		<description><![CDATA[Vitamins, minerals, trace minerals, essential fatty acids, amino acids, antioxidants and other nutrients have often been removed from our civilized food chain by the effects of modern agricultural methods and food processing. Hence, their adequate supplementation in a nutrient-depleted body will greatly enhance the chance for a successful, long life, lived to its maximum potential. Catastrophic modern diseases such as cancer or heart disease can actually be beaten when a person decided to]]></description>
			<content:encoded><![CDATA[Vitamins, minerals, trace minerals, essential fatty acids, amino acids, antioxidants and other nutrients have often been removed from our civilized food chain by the effects of modern agricultural methods and food processing. Hence, their adequate supplementation in a nutrient-depleted body will greatly enhance the chance for a successful, long life, lived to its maximum potential. Catastrophic modern diseases such as cancer or heart disease can actually be beaten when a person decided to]]></content:encoded>
			<wfw:commentRss>http://www.hipkneebook.com/main-content/nutrition-and-supplements-in-anti-aging-medicine/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Target the Epstein Barr, Hepatitis, and Herpes Viruses with Gene-Eden, a Broad Range, Natural Antiviral Supplement</title>
		<link>http://www.hipkneebook.com/main-content/target-the-epstein-barr-hepatitis-and-herpes-viruses-with-gene-eden-a-broad-range-natural-antiviral-supplement/</link>
		<comments>http://www.hipkneebook.com/main-content/target-the-epstein-barr-hepatitis-and-herpes-viruses-with-gene-eden-a-broad-range-natural-antiviral-supplement/#comments</comments>
		<pubDate>Mon, 12 Oct 2009 13:29:29 +0000</pubDate>
		<dc:creator>Content Keyword RSS</dc:creator>
				<category><![CDATA[Main Content]]></category>
		<category><![CDATA[Arthritis]]></category>
		<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Diabetes]]></category>
		<category><![CDATA[Eden]]></category>
		<category><![CDATA[Epstein Barr]]></category>
		<category><![CDATA[Heart Disease]]></category>
		<category><![CDATA[Hepatitis]]></category>
		<category><![CDATA[Herpes]]></category>
		<category><![CDATA[Herpes Viruses]]></category>
		<category><![CDATA[Natural Supplement]]></category>
		<category><![CDATA[Target]]></category>

		<guid isPermaLink="false">http://www.christianwomensresources.com/target-the-epstein-barr-hepatitis-and-herpes-viruses-with-gene-eden-a-broad-range-natural-antiviral-supplement/</guid>
		<description><![CDATA[Worried about cancer, and diabetes, and arthritis, and heart disease? Want to do something to protect yourself? Now you can.]]></description>
			<content:encoded><![CDATA[Worried about cancer, and diabetes, and arthritis, and heart disease? Want to do something to protect yourself? Now you can.]]></content:encoded>
			<wfw:commentRss>http://www.hipkneebook.com/main-content/target-the-epstein-barr-hepatitis-and-herpes-viruses-with-gene-eden-a-broad-range-natural-antiviral-supplement/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Latent Viruses Cause Cancer – Stop Latent Viruses with Gene-Eden, an Antiviral Supplement</title>
		<link>http://www.hipkneebook.com/main-content/latent-viruses-cause-cancer-%e2%80%93-stop-latent-viruses-with-gene-eden-an-antiviral-supplement/</link>
		<comments>http://www.hipkneebook.com/main-content/latent-viruses-cause-cancer-%e2%80%93-stop-latent-viruses-with-gene-eden-an-antiviral-supplement/#comments</comments>
		<pubDate>Wed, 07 Oct 2009 20:25:13 +0000</pubDate>
		<dc:creator>Content Keyword RSS</dc:creator>
				<category><![CDATA[Main Content]]></category>
		<category><![CDATA[Blood Pressure]]></category>
		<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Cell Phone Antenna]]></category>
		<category><![CDATA[Cholesterol]]></category>
		<category><![CDATA[Eden]]></category>
		<category><![CDATA[Enemies]]></category>
		<category><![CDATA[Immune System]]></category>
		<category><![CDATA[Lowering Your Cholesterol]]></category>
		<category><![CDATA[Powerful System]]></category>
		<category><![CDATA[Stress]]></category>
		<category><![CDATA[Viruses]]></category>

		<guid isPermaLink="false">http://naked-news.net/latent-viruses-cause-cancer-stop-latent-viruses-with-gene-eden-an-antiviral-supplement-20091007</guid>
		<description><![CDATA[Latent Viruses Cause Cancer – Stop Latent Viruses with Gene-Eden, an Antiviral Supplement by Rachel MikelThe immune system is a very powerful system, but it?s not indestructible. It has many external and internal enemies. For example, are you under a lot of stress? Do you take medications for lowering your cholesterol, or blood pressure, or to control other long term conditions? Are you using your cell phone extensively? Do you live or work next to a cell phone antenna? Were you exposed]]></description>
			<content:encoded><![CDATA[Latent Viruses Cause Cancer – Stop Latent Viruses with Gene-Eden, an Antiviral Supplement by Rachel MikelThe immune system is a very powerful system, but it?s not indestructible. It has many external and internal enemies. For example, are you under a lot of stress? Do you take medications for lowering your cholesterol, or blood pressure, or to control other long term conditions? Are you using your cell phone extensively? Do you live or work next to a cell phone antenna? Were you exposed]]></content:encoded>
			<wfw:commentRss>http://www.hipkneebook.com/main-content/latent-viruses-cause-cancer-%e2%80%93-stop-latent-viruses-with-gene-eden-an-antiviral-supplement/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
